These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32429139)

  • 1. Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly-A Practical Guideline.
    Zintzsch A; Noe E; Grimm H
    Animals (Basel); 2020 May; 10(5):. PubMed ID: 32429139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necessary, but Not Sufficient. The Benefit Concept in the Project Evaluation of Animal Research in the Context of Directive 2010/63/EU.
    Eggel M; Grimm H
    Animals (Basel); 2018 Feb; 8(3):. PubMed ID: 29495562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm-Benefit Analysis May Not Be the Best Approach to Ensure Minimal Harms and Maximal Benefits of Animal Research-Alternatives Should Be Explored.
    Gutfreund Y
    Animals (Basel); 2020 Feb; 10(2):. PubMed ID: 32059540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm-benefit analysis - what is the added value? A review of alternative strategies for weighing harms and benefits as part of the assessment of animal research.
    Grimm H; Olsson IAS; Sandøe P
    Lab Anim; 2019 Feb; 53(1):17-27. PubMed ID: 29966482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Road to Hell Is Paved with Good Intentions: Why Harm-Benefit Analysis and Its Emphasis on Practical Benefit Jeopardizes the Credibility of Research.
    Grimm H; Eggel M; Deplazes-Zemp A; Biller-Andorno N
    Animals (Basel); 2017 Sep; 7(9):. PubMed ID: 28892015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mission impossible accomplished? A European cross-national comparative study on the integration of the harm-benefit analysis into law and policy documents.
    Hajosi D; Grimm H
    PLoS One; 2024; 19(2):e0297375. PubMed ID: 38377057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines on severity assessment and classification of genetically altered mouse and rat lines.
    Zintzsch A; Noe E; Reißmann M; Ullmann K; Krämer S; Jerchow B; Kluge R; Gösele C; Nickles H; Puppe A; Rülicke T
    Lab Anim; 2017 Dec; 51(6):573-582. PubMed ID: 28696160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case for integrity: gains from including more than animal welfare in animal ethics committee deliberations.
    Röcklinsberg H; Gamborg C; Gjerris M
    Lab Anim; 2014 Jan; 48(1):61-71. PubMed ID: 24367033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for Addressing Harm-Benefit Analysis and Implementation in Ethical Evaluation - Report from the AALAS-FELASA Working Group on Harm-Benefit Analysis - Part 2.
    Laber K; Newcomer CE; Decelle T; Everitt JI; Guillen J; Brønstad A
    Lab Anim; 2016 Jun; 50(1 Suppl):21-42. PubMed ID: 27188276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On balance: weighing harms and benefits in fundamental neurological research using nonhuman primates.
    Arnason G; Clausen J
    Med Health Care Philos; 2016 Jun; 19(2):229-37. PubMed ID: 26351063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidance on determining indispensability and balancing potential benefits of animal experiments with costs to the animals with specific consideration of EU directive 2010/63/EU.
    Lindl T; Gross U; Ruhdel I; von Aulock S; Völkel M
    ALTEX; 2012; 29(2):219-28. PubMed ID: 22562491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical review of projects involving non-human primates funded under the European Union's 7th Research Framework Programme.
    Sauer U; Phillips B; Reid K; Schmit V; Jennings M
    Altern Lab Anim; 2013 Sep; 41(4):271-306. PubMed ID: 24168134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dividing Line Between Wildlife Research and Management-Implications for Animal Welfare.
    Lindsjö J; Cvek K; Spangenberg EMF; Olsson JNG; Stéen M
    Front Vet Sci; 2019; 6():13. PubMed ID: 30805350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
    Sauer UG; Kolar R; Rusche B
    ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the Care and Welfare of Cephalopods in Research -A consensus based on an initiative by CephRes, FELASA and the Boyd Group.
    Fiorito G; Affuso A; Basil J; Cole A; de Girolamo P; D'Angelo L; Dickel L; Gestal C; Grasso F; Kuba M; Mark F; Melillo D; Osorio D; Perkins K; Ponte G; Shashar N; Smith D; Smith J; Andrews PL
    Lab Anim; 2015 Jul; 49(2 Suppl):1-90. PubMed ID: 26354955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical difficulties in balancing harms and benefits in the modern use of laboratory animals: biotechnology.
    Buning Tde C
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():459-63. PubMed ID: 23581118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emotions and Ethical Decision-Making in Animal Ethics Committees.
    Tjärnström E; Weber EM; Hultgren J; Röcklinsberg H
    Animals (Basel); 2018 Oct; 8(10):. PubMed ID: 30336584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effects of presenting uncertainty around benefits and harms on treatment decision making.
    Sladakovic J; Jansen J; Hersch J; Turner R; McCaffery K
    Patient Educ Couns; 2016 Jun; 99(6):974-80. PubMed ID: 26823204
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.